Biomerica, Inc. (BMRA)Healthcare | Medical Devices | Irvine, United States | NasdaqCM
1.69 USD
After hours: 1.69 |
Hot Take ↕ | July 11, 2026, 5:19 a.m. EDT
The immediate outlook is severely clouded by deteriorating fundamentals and a broken price trend. The company is currently burning cash, with operating cash flow and free cash flow both deeply negative, while profit margins have collapsed to nearly -96%. This financial distress is reflected in the stock's performance, which has suffered a catastrophic 74% decline over the last nine years, despite a recent minor uptick in annual returns. The price action confirms this weakness, trading well below its 50-day and 200-day moving averages, indicating persistent selling pressure. With no analyst recommendations, a lack of dividends, and a balance sheet showing negative returns on equity and assets, there is no compelling case for a near-term bounce or a long-term recovery. The statistical forecast model offers a tiny upside prediction, but its extremely low reliability makes it irrelevant against the backdrop of such profound structural damage. |
| Model | MAE |
|---|---|
| MSTL_79 ✓ | 0.087961 |
| AutoTheta | 0.090258 |
| AutoARIMA | 0.092405 |
| MSTL | 0.092839 |
| AutoETS | 0.092995 |
| MSTL_105 | 0.151465 |
| MSTL_79_105 | 0.213148 |
Forecast horizon: 60 days | Selected: MSTL_79
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 26.13 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.072 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.819 |
| Revenue per Share | 1.608 |
| Market Cap | 5,222,555 |
| Forward P/E | 4.33 |
| Beta | 0.33 |
| Profit Margins | -96.46% |
| Website | https://www.biomerica.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.44224423 |
| Address1 | 17,571 Von Karman Avenue |
| All Time High | 187.12 |
| All Time Low | 1.36 |
| Ask | 2.13 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 6,680 |
| Average Daily Volume3 Month | 17,462 |
| Average Volume | 17,462 |
| Average Volume10Days | 6,680 |
| Beta | 0.332 |
| Bid | 1.22 |
| Bid Size | 2 |
| Book Value | 1.095 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.69 |
| Current Ratio | 2.641 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.7499 |
| Day Low | 1.66 |
| Debt To Equity | 5.819 |
| Display Name | Biomerica |
| Earnings Timestamp End | 1,756,756,800 |
| Earnings Timestamp Start | 1,756,238,400 |
| Ebitda | -5,268,000 |
| Ebitda Margins | -1.21747 |
| Enterprise To Ebitda | -0.774 |
| Enterprise To Revenue | 0.943 |
| Enterprise Value | 4,079,554 |
| Eps Forward | 0.39 |
| Eps Trailing Twelve Months | -1.59 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 949 553 1231 |
| Fifty Day Average | 2.0804 |
| Fifty Day Average Change | -0.39039993 |
| Fifty Day Average Change Percent | -0.1876562 |
| Fifty Two Week Change Percent | -44.224422 |
| Fifty Two Week High | 4.6 |
| Fifty Two Week High Change | -2.9099998 |
| Fifty Two Week High Change Percent | -0.63260865 |
| Fifty Two Week Low | 1.64 |
| Fifty Two Week Low Change | 0.05000007 |
| Fifty Two Week Low Change Percent | 0.030487848 |
| Fifty Two Week Range | 1.64 - 4.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 463,411,800,000 |
| Float Shares | 2,774,011 |
| Forward Eps | 0.39 |
| Forward P E | 4.3333335 |
| Free Cashflow | -2,028,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.04368 |
| Gross Profits | 189,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15239 |
| Held Percent Institutions | 0.03616 |
| Implied Shares Outstanding | 3,090,269 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.biomerica.com/company/investor.asp |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,748,649,600 |
| Last Split Date | 1,745,193,600 |
| Last Split Factor | 1:8 |
| Long Business Summary | Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. |
| Long Name | Biomerica, Inc. |
| Market | us_market |
| Market Cap | 5,222,555 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_254941 |
| Most Recent Quarter | 1,772,236,800 |
| Net Income To Common | -4,174,000 |
| Next Fiscal Year End | 1,780,185,600 |
| Non Diluted Market Cap | 5,222,554 |
| Open | 1.6501 |
| Operating Cashflow | -3,170,000 |
| Operating Margins | -1.3151 |
| Payout Ratio | 0.0 |
| Phone | 949 645 2111 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.69 |
| Post Market Time | 1,783,973,097 |
| Previous Close | 1.69 |
| Price Hint | 4 |
| Price To Book | 1.543379 |
| Price To Sales Trailing12 Months | 1.206969 |
| Profit Margins | -0.96463996 |
| Quick Ratio | 1.459 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 1.7499 |
| Regular Market Day Low | 1.66 |
| Regular Market Day Range | 1.66 - 1.7499 |
| Regular Market Open | 1.6501 |
| Regular Market Previous Close | 1.69 |
| Regular Market Price | 1.69 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 6,627 |
| Return On Assets | -0.54584 |
| Return On Equity | -0.94317 |
| Revenue Growth | -0.118 |
| Revenue Per Share | 1.608 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,090,269 |
| Shares Percent Shares Out | 0.0106 |
| Shares Short | 32,611 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 79,979 |
| Short Name | Biomerica, Inc. |
| Short Percent Of Float | 0.0119 |
| Short Ratio | 1.69 |
| Source Interval | 15 |
| State | CA |
| Symbol | BMRA |
| Total Cash | 1,336,000 |
| Total Cash Per Share | 0.432 |
| Total Debt | 193,000 |
| Total Revenue | 4,327,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.59 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.34055 |
| Two Hundred Day Average Change | -0.6505499 |
| Two Hundred Day Average Change Percent | -0.27794746 |
| Type Disp | Equity |
| Volume | 6,627 |
| Website | https://www.biomerica.com |
| Zip | 92,614 |